Literature DB >> 27202126

Drug Survival Rates And Cost of Biological Agents for the Treatment of Moderate to Severe Psoriasis in the Balearic Islands (Spain).

P Ventayol1.   

Abstract

Entities:  

Year:  2014        PMID： 27202126     DOI： 10.1016/j.jval.2014.08.2135

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review.

Authors:  Lluís Puig; Lourdes Rodríguez Fernández-Freire; Ramón Burgos-Pol; Ismael Gomez; Carmen Peral; Susana Gomez; Francisco José Rebollo Laserna
Journal:  Dermatol Ther (Heidelb)       Date:  2019-05-06

2.  Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence.

Authors:  Pei-Tzu Lin; Shu-Hui Wang; Ching-Chi Chi
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.